Artificial intelligence (AI) is rapidly transforming the landscape of drug discovery and development, offering unparalleled opportunities to accelerate the development of new therapies and improve patient outcomes. The traditional ...

In recent years, gene editing therapy has emerged as a promising approach to treating genetic disorders and diseases. With advances in technology, scientists are now able to precisely edit ...

Patents are important in AI drug discovery. Patents provide a way for companies to protect their innovations and investments in AI drug discovery, giving them exclusive rights to use ...

Gene editing therapy represents a new frontier in medicine and has the potential to revolutionize the treatment of a variety of diseases and conditions. While traditional treatments manage symptoms ...

As the world is facing threats of a major recession in the slipstream of the Covid-19 pandemic, the AI drug development industry is caught in a limbo with hesitating ...

Funding for artificial intelligence in drug development hit $4.1B in 2021, a 36% increase from the year before. The AI drug development industry has gained a lot of attention ...

Canada’s early contributions and long-standing expertise in artificial intelligence (AI) have proven valuable when it comes to AI applications in drug development. After several years where the industry has ...

The world market for AI applications in drug development is projected to reach $5.1 billion by 2025 with a CAGR of 29.6%, an increase of over $3.6 billion from ...